We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 17.75 | 17.50 | 18.00 | 17.75 | 17.75 | 17.75 | 58,159 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.25 | 16.19M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/5/2018 07:55 | As I said big things just around the corner:-) but guess we all know that anyway. Good news just keeps coming... | zebbo | |
22/5/2018 07:51 | "agreement with Seed Health ('SeedTM') to produce, promote, market, and commercialise products containing LP-LDL® in the USA."Products (plural). And from recent articles we know we are looking at one for women and one for men as a minimum. | parob | |
22/5/2018 07:45 | Key metrics to look out for tomorrow. Will they mention any of the following? Results are six months out of date, so they need to state:- 1) Cash remaining now. Not end November 2017. 2) Revenues received from December 2017 to end May 2018. 3) Year end predictions for revenues and losses/profits. Today's RNS is as woolly as ever. No figures mentioned just the usual b*llsh*t about the size of the market which is a total irrelevance e.g. Coffee shop market is massive and worth billions, but try opening a chain now and see how you get on penetrating this billion dollar market! Results tomorrow and perhaps they'll surprise with figures going forward, but I won't hold my breath. | michaelmouse | |
22/5/2018 07:09 | Lovely. Shame RNS's have to be a bit bland.. would be great to have included Peter Thiel, Cameron Diaz Jessica Beil and Karlie Kloss as backers | trotterstrading | |
22/5/2018 07:08 | We know the product is to launch imminently meaning instant revenues. No wonder SOH has been so confident we will hit break even this year.Get ready for a big publicity and marketing campaign to kick in.High profile backers. Revolutionary science. Ripe market.Seed Health is a game changer. | parob | |
22/5/2018 07:05 | At last the announcement. Now let the publicity begin. | rafboy | |
22/5/2018 07:02 | LP-LDL® agreement for USA OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces that it has entered into a non-exclusive agreement with Seed Health ('SeedTM') to produce, promote, market, and commercialise products containing LP-LDL® in the USA. OptiBiotix previously announced (RNS: 1 May 2018) that it was in commercial discussions with SeedTM in response to media reports on the launch of its LP-LDL® product in the USA. This announcement confirms the successful conclusion of those discussions. SeedTM (seed.com) was cofounded and is led by Raja Dhir and Ara Katz to pioneer the application of microbiome science to improve human and planetary health. In collaboration with leading microbiome scientists and a global network of partners and experts in biofermentation, stabilisation and testing, SeedTM state they have developed a new standard for a pipeline of effective, scientifically-valid This agreement is a strategic step by OptiBiotix to access the US probiotic supplement market. The US is one of the largest and fastest growing probiotic markets in the world, with supplements alone accounting for $2.06 billion sales, with a projected 55% growth to $3.3 billion by 2021*. LP-LDL® will be commercialised by SeedTM in an innovative product concept which combines multiple strains of different probiotics which have been selected because of strong clinical trial data. OptiBiotix's LP-LDL® strain has published human data demonstrating statistical and clinical significant reductions in cholesterol and blood pressure, won best scientific abstracts at both ProBiota 2017 and ProBiota 2018, and was finalist as ProBiotic of the year at Vitafoods 2018. *Market data from 'TRENDS, INNOVATIONS AND OPPORTUNITIES DRIVING THE GLOBAL PROBIOTICS MARKET' (Euromonitor International June 2017). Stephen O'Hara, CEO of OptiBiotix, commented: "We are pleased to announce this agreement with SeedTM which extends the sale of LP-LDL® into the USA, the world's largest and fastest growing probiotic market. We chose SeedTM due to our shared vision of commercialising products with strong scientific and clinical data, their innovative product concept, and their ability to access the large USA consumer goods market. We are pleased that our strong science, successful human studies and international awards at major scientific conferences has attracted international interest in our products leading to continued regular deal flow as we build multiple revenue streams from partners across the world." | daftbat | |
22/5/2018 07:02 | I'm new to this, are you seeing these buys and sells on level 2? | robo28 | |
21/5/2018 22:44 | Suggest you don't watch every trade 🤗🤑 | zebbo | |
21/5/2018 15:53 | The market is not a straight bat game it seems. We should be higher today, so frustrating to see. | rafboy | |
21/5/2018 15:46 | Yep there certainly is some lost ground to make up. The 100k plus and 20k plus buys this pm look encouraging... | bobdown2 | |
21/5/2018 14:07 | TT, how is it plain for all to see? I'm seeing 100k more buys over sells, yet we are 1p down and one trade cost a premium. | slartybartfaster | |
21/5/2018 13:43 | Rathen the ramper has a lot to learn. No share is a sure fire winner. | monkeywench1 | |
21/5/2018 13:39 | May be now we can regain the ground lost earlier. | rafboy | |
21/5/2018 13:09 | MM Games mate, no conspiracy, plain for all to see | trotterstrading | |
21/5/2018 13:00 | elrico's buddy still hoovering stock up at a premium. How come you didn't tip the wink elrico? Oh yeah, still sulking. Big hugs. :) | slartybartfaster | |
21/5/2018 12:51 | With that 111111 buy why are we down? | rafboy | |
21/5/2018 12:19 | If SOH can position the results right and more importantly the outlook, we could move sharply higher. Another golden opportunity to shine | zebbo | |
21/5/2018 12:15 | monkey filtered, he's offered nothing but provocation. I'm not a ramper of this stock, I think it's a sure fire winner in time but unless there are compelling numbers on Wednesday I can see this dropping back down into its 2 year trading channel. It's getting exciting though, like waiting for Xmas :) | rathean | |
21/5/2018 10:26 | Wednesday morning will make interesting reading.Firstly, of course, is the official progress up to the end of November. That is six months out of date.Where it gets interesting is the content of what has happened since and particularly most recent developments. I do not envy the position that SOH finds himself in. Such an embarrassment of riches on which he has to avoid any excess enthusiasm. I am sure he will cope very well as we know he can. | aspex | |
21/5/2018 10:21 | Literally a Conveyor belt of deals heading our way ;0) | trotterstrading | |
21/5/2018 10:13 | Whoop whoop, finally worked out how to ignore someone on ADVFN - don't know if this is the same as filtering but their messages come up totally blank now, so thats good enough for me. : )Good riddance to Moneywench's useless babble.Sienna. | siennadelekat21 | |
21/5/2018 09:38 | Opti are definitely ticking all the boxes and will become the number 1 supplier of key microbiotic ingredients IMHO. Momentum is the key to achieving this status and we have it in spades and all underpinned by science FYB | zebbo | |
21/5/2018 09:36 | On the other thread, it looks like Skin has woken up with a smile on its face 😔 John | 2350220 | |
21/5/2018 09:17 | Optibiotix-scoops-aw | primal123 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions